Clinical Trial: Clinical Effect of Rebamipide on Chronic Gastritis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Clinical Effect of Rebamipide on Chronic Gastritis

Brief Summary: To investigate the clinical effect of rebamipide in chronic gastritis patients. Patients with chronic gastritis were randomly divided into the experimental group and the control group. The experimental group were treated with rebamipide 0.1g tid and optimization of life style, and the control group were only optimized their life style for 26 weeks. Upper gastrointestinal endoscopy was performed in all patients to evaluate the severity of gastritis by modified Lanza score (MLS) and the histology by the updated Sydney system before and after treatment.

Detailed Summary:
Sponsor: BangMao Wang

Current Primary Outcome:

• modified Lanza score [ Time Frame: 26 weeks ]
• visual Analog scale [ Time Frame: 26 weeks ]
  to describe the inflamamtory of gastric mucosa pathologically

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Tianjin Medical University General Hospital

Dates:
Date Received: November 23, 2014
Date Started: May 2012
Date Completion:
Last Updated: March 15, 2015
Last Verified: March 2015